Why is Sudarshan Pharma Industries Ltd ?
1
Flat results in Sep 26
- DPR(Y) Lowest at 0.00%
- INTEREST(Q) Highest at Rs 10.36 cr
2
Stock is technically in a Mildly Bearish range
- The technical trend has deteriorated from Mildly Bullish on 20-Nov-26
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sudarshan Pharma for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Sudarshan Pharma
28.28%
0.50
56.13%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
28.10%
EBIT Growth (5y)
47.89%
EBIT to Interest (avg)
1.98
Debt to EBITDA (avg)
6.06
Net Debt to Equity (avg)
2.00
Sales to Capital Employed (avg)
1.43
Tax Ratio
26.22%
Dividend Payout Ratio
0
Pledged Shares
23.26%
Institutional Holding
22.00%
ROCE (avg)
9.89%
ROE (avg)
14.86%
Valuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
40
Price to Book Value
3.75
EV to EBIT
17.91
EV to EBITDA
16.65
EV to Capital Employed
1.92
EV to Sales
1.44
PEG Ratio
0.87
Dividend Yield
NA
ROCE (Latest)
10.71%
ROE (Latest)
14.86%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Technical Movement
16What is working for the Company
NET SALES(Latest six months)
At Rs 391.39 cr has Grown at 24.59%
PBT LESS OI(Q)
At Rs 8.87 cr has Grown at 48.4% (vs previous 4Q average
PBDIT(Q)
Highest at Rs 20.59 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 9.49%
PAT(Q)
At Rs 8.09 cr has Grown at 28.8% (vs previous 4Q average
-11What is not working for the Company
DPR(Y)
Lowest at 0.00%
INTEREST(Q)
Highest at Rs 10.36 cr
Loading Valuation Snapshot...
Here's what is working for Sudarshan Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 8.87 cr has Grown at 48.4% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 5.98 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Latest six months
At Rs 391.39 cr has Grown at 24.59%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 20.59 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 9.49%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit After Tax (PAT) - Quarterly
At Rs 8.09 cr has Grown at 28.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 6.28 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Sudarshan Pharma
Interest - Quarterly
At Rs 10.36 cr has Grown at 26.19%
Quarter on Quarter (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Interest - Quarterly
Highest at Rs 10.36 cr
in the last five quarters and Increased by 26.19 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Dividend Payout Ratio (DPR) - Annually
Lowest at 0.00%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)